miRNAs and T cell-mediated Immune Response in Disease

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) are key regulators of gene expression.
• T cell differentiation is crucial in immune responses and disease pathogenesis.
• Dysregulated T cell function underlies various cardiometabolic and autoimmune diseases.

Purpose of the Study:

• To review the role of miRNAs in T cell differentiation and function across multiple inflammatory diseases.
• To identify specific miRNA expression patterns associated with different disease types.
• To explore the potential of miRNAs in predicting disease progression and therapeutic response.

Main Methods:

• Literature review of studies on miRNA regulation of T cells in cardiometabolic and autoimmune diseases.
• Analysis of miRNA expression profiles in obesity, type 2 diabetes, atherosclerosis, type 1 diabetes, rheumatoid arthritis, asthma, and cancer.
• Correlation of miRNA expression with T cell subset differentiation and disease characteristics.

Main Results:

• Distinct miRNA profiles characterize different diseases, influencing T helper 1/17, T helper 2, cytotoxic, regulatory T cells, and myeloid-derived suppressor cells.
• Specific miRNAs (e.g., miR-155, Let-7 cluster, miR-21, miR-29, miR-150) are implicated in disease pathogenesis and progression.
• Certain miRNA patterns are associated with protection against tissue damage but may promote tumor growth.

Conclusions:

• miRNAs play a critical role in shaping T cell responses in inflammatory diseases.
• miRNA expression signatures can serve as biomarkers for disease progression and therapeutic targets.
• Further research into miRNA clusters could optimize disease management and reduce treatment costs.